Do adjunct tuberculosis tests, when combined with Xpert MTB/RIF, improve accuracy and the cost of diagnosis in a resource-poor setting? - Wikidata - wikimedia - TriplyDB

Do adjunct tuberculosis tests, when combined with Xpert MTB/RIF, improve accuracy and the cost of diagnosis in a resource-poor setting?

Do adjunct tuberculosis tests, when combined with Xpert MTB/RIF, improve accuracy and the cost of diagnosis in a resource-poor setting?

http://www.wikidata.org/entity/Q33924814

about

Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults Point-of-care diagnosis of tuberculosis: past, present and future A bispecific antibody based assay shows potential for detecting tuberculosis in resource constrained laboratory settings Population health impact and cost-effectiveness of tuberculosis diagnosis with Xpert MTB/RIF: a dynamic simulation and economic evaluation Time to treatment and patient outcomes among TB suspects screened by a single point-of-care xpert MTB/RIF at a primary care clinic in Johannesburg, South Africa The diagnostic performance of a single GeneXpert MTB/RIF assay in an intensified tuberculosis case finding survey among HIV-infected prisoners in Malaysia The diagnostic accuracy of urine-based Xpert MTB/RIF in HIV-infected hospitalized patients who are smear-negative or sputum scarce Correlation of mycobacterium tuberculosis specific and non-specific quantitative Th1 T-cell responses with bacillary load in a high burden setting Digital CXR with computer aided diagnosis versus symptom screen to define presumptive tuberculosis among household contacts and impact on tuberculosis diagnosis.An evaluation of automated chest radiography reading software for tuberculosis screening among public- and private-sector patients.Point-of-care lateral flow assays for tuberculosis and cryptococcal antigenuria predict death in HIV infected adults in Uganda Population-level impact of same-day microscopy and Xpert MTB/RIF for tuberculosis diagnosis in Africa.The sensitivity and specificity of using a computer aided diagnosis program for automatically scoring chest X-rays of presumptive TB patients compared with Xpert MTB/RIF in Lusaka Zambia.Implementation Research to Inform the Use of Xpert MTB/RIF in Primary Health Care Facilities in High TB and HIV Settings in Resource Constrained Settings The use of an automated quantitative polymerase chain reaction (Xpert MTB/RIF) to predict the sputum smear status of tuberculosis patients.Automated chest-radiography as a triage for Xpert testing in resource-constrained settings: a prospective study of diagnostic accuracy and costs Rapid implementation of new TB diagnostic tests: is it too soon for a global roll-out of Xpert MTB/RIF?Cost-effectiveness analysis of microscopic observation drug susceptibility test versus Xpert MTB/Rif test for diagnosis of pulmonary tuberculosis in HIV patients in Uganda.Comparison of two methods for acquisition of sputum samples for diagnosis of suspected tuberculosis in smear-negative or sputum-scarce people: a randomised controlled trial.Screening for pulmonary tuberculosis in a Tanzanian prison and computer-aided interpretation of chest X-rays.Scaling up Xpert MTB/RIF technology: the costs of laboratory- vs. clinic-based roll-out in South Africa.Assessing the utility of Xpert(®) MTB/RIF as a screening tool for patients admitted to medical wards in South Africa.Multicenter evaluation of genechip for detection of multidrug-resistant Mycobacterium tuberculosis.The Use of Xpert MTB/Rif for Active Case Finding among TB Contacts in North West Province, South Africa.Incorporating Demand and Supply Constraints into Economic Evaluations in Low-Income and Middle-Income Countries Detection of the tuberculosis antigenic marker mannose-capped lipoarabinomannan in pretreated serum by surface-enhanced Raman scattering.Diagnostic accuracy of C-reactive protein for active pulmonary tuberculosis: a meta-analysis.A two-step algorithm for rapid diagnosis of active pulmonary tuberculosis in entry applicants using the T-SPOT.TB and Xpert MTB/RIF assays in Shanghai, China.False positive Xpert MTB/RIF results in re-tested patients with previous tuberculosis: frequency, profile, and prospective clinical outcomes.The impact of implementing a Xpert MTB/RIF algorithm on drug-sensitive pulmonary tuberculosis: a retrospective analysis.Empiric tuberculosis treatment in South African primary health care facilities - for whom, where, when and why: Implications for the development of tuberculosis diagnostic tests.A Comprehensive Evaluation of Xpert MTB/RIF Assay With Bronchoalveolar Lavage Fluid as a Single Test or Combined With Conventional Assays for Diagnosis of Pulmonary Tuberculosis in China: A Two-Center Prospective Study.Evaluating a framework for tuberculosis screening among healthcare workers in clinical settings, Inner Mongolia, China.Evaluation of the diagnostic accuracy of Computer-Aided Detection of tuberculosis on Chest radiography among private sector patients in Pakistan

P2860

Q24200879-F03A368A-AF35-4619-B072-17B4454D782F Q27004667-FD91ECF9-A235-484E-A952-C15D7753C14A Q28481078-3A24C80F-6BBB-4C49-BBDB-6DA3AD8BEB44 Q28485280-A09604CE-0CD5-4945-8EA3-DD0A707FFA7D Q28533713-6BA60AD3-16CE-427C-96B6-D0E873D1FF31 Q28536945-FC63060C-D4C4-4765-835D-E4AB161A21AF Q28727351-0B381983-2D2B-4C66-BD48-6C001CBEFB69 Q28729742-CB0E1B81-CEF8-486C-A17A-4FF89C2C2CCB Q33595614-6CA48603-DD6D-4E7C-AC9B-A0D0B912F1F2 Q33768767-C3AE7AB2-6971-41FD-A7FB-948E28D6C97C Q33855961-A55B4372-9FA2-4EAC-B80D-4CCD073036C7 Q34947034-AF0E81A5-F5B2-43F2-A630-33268CD1F7A5 Q35140397-A1BF2C03-6808-4143-9B29-F337279AFA27 Q35647887-47E49D11-3A6F-48C6-B9AC-00D9E37CE6E3 Q35672549-9A30C29B-2EC7-4844-910B-949303D9B1F5 Q35891122-CF1916D6-4212-49BF-8FE8-3892B110809D Q36149564-F31BD7BE-32DF-4BE3-B4E7-CBC1F9B5F5C6 Q36159840-DD7EA80D-6C44-44D4-9963-2912BC772B89 Q36246188-36E0894F-54B3-486D-B3CA-323DC55B43A9 Q36380623-C9DBE029-EEE5-4444-9028-EAD48A763316 Q36424212-C40B441F-85DD-4601-9041-EABAE99F21FC Q36501101-27D38FA6-53A9-4D75-B6E3-0247CB2A2E4C Q37026454-39FF28AA-4B5E-4ACD-89C1-402770653916 Q37132278-13D8B157-1D88-484D-83C1-8282E5ADBF70 Q37295972-DDF9F761-4DCD-467E-95E8-53FA657D21F6 Q38376927-27C0168C-8435-4C0A-9BEE-AE5D44FB14DD Q40076558-80F36510-5B4D-4B9D-81CF-89F444333BF7 Q40119233-4DBFFB3C-0A0D-45CE-B6DE-90877E6E84DE Q47203491-5F15C8C0-4B58-486A-BCF7-B1C71D82738F Q47363892-2A4BD56B-A49D-426D-84DE-5BFF6A078F16 Q48173794-93312922-89DE-45C5-B721-D254F4F39675 Q52624528-A730A15C-01A2-4D81-937F-AB08AC3D3037 Q52645915-6CA258EB-6369-4AAB-8F23-75C9DE1654D0 Q57943196-EECFA33C-2E5D-428F-8150-4C87CC8535B6

P2860

Do adjunct tuberculosis tests, when combined with Xpert MTB/RIF, improve accuracy and the cost of diagnosis in a resource-poor setting?

http://www.wikidata.org/entity/Q33924814

description

2011 nî lūn-bûn

@nan

2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Do adjunct tuberculosis tests, ...... is in a resource-poor setting?

@ast

Do adjunct tuberculosis tests, ...... is in a resource-poor setting?

@en

type

label

Do adjunct tuberculosis tests, ...... is in a resource-poor setting?

@ast

Do adjunct tuberculosis tests, ...... is in a resource-poor setting?

@en

prefLabel

Do adjunct tuberculosis tests, ...... is in a resource-poor setting?

@ast

Do adjunct tuberculosis tests, ...... is in a resource-poor setting?

@en

P1433

Q33924814-8447B1DF-44A8-4A52-B5B0-EDD1D6BC6A56

P1476

Q33924814-32192F3F-913E-4F1A-B127-23DA3797258D

P2093

Q33924814-0BF824B8-D949-4B52-BAA6-7B0A6B22D094

Q33924814-123C3769-1B69-4869-A5FF-1443982ABD5F

Q33924814-1B841090-4AA8-4DF9-98C0-1A9B1B12D104

Q33924814-2FA71DD8-01CA-42B6-9F67-99ECB4156877

Q33924814-3385F518-0637-4990-A14C-6F2C9ED2B247

Q33924814-8AF9AEDE-77F6-4D96-990A-E82BB15A473D

Q33924814-9695F174-5D60-426D-9288-0DD9DA9EBA10

Q33924814-97A13A9A-29AE-47E8-8056-359A4D679F93

Q33924814-B2A7FBA9-8384-4B12-AF06-6335534B28BD

Q33924814-EFB9305D-8919-439F-970D-87EA1B4389E9

P2860

Q33924814-041C6F60-2C83-41B7-AB59-20330B939CD4

Q33924814-0C8C535B-AB73-44B7-A40D-34E37F7E2D0F

Q33924814-2101EC40-F48C-4F3E-83EE-013EBC691DFC

Q33924814-2247CFDA-474C-4F22-920F-1389A2A12C84

Q33924814-30FC8C8B-A611-4533-8B07-B206443153C9

Q33924814-3DCC1E0D-EA98-400B-8DB9-E6FEEF51D4D5

Q33924814-4D14E1A8-ECA2-4871-98BE-51898210C0F8

Q33924814-789812CC-8E36-4E27-B3CD-97FD49C57697

Q33924814-B5D14419-2131-46BB-9B19-FF6349B9B44D

Q33924814-C9E22E90-2025-428D-BC3F-B3FF36A70ECB

P304

Q33924814-F244CED0-0192-47B3-A72E-DE81C6C26E24

P31

Q33924814-1D53DC65-7039-4A20-B914-3EC4D9A93AD6

P356

Q33924814-10C755ED-F4D6-4897-8F42-D0FCF34E8A56

P433

Q33924814-721E579A-6047-4239-B9D1-513859782ED2

P478

Q33924814-1F1FF560-BF88-4410-829F-C62FD6E9A473

P50

Q33924814-966E9F66-D1FC-45B2-BF7B-EC4CDB33BEDB

P577

Q33924814-E3C39345-8278-4E52-A54A-5A6AB9428C8A

P5875

Q33924814-6CCB72EE-8B74-409B-84E6-44B8F85B38FC

P698

Q33924814-F5D7EF9E-5082-4D21-A6FA-504C08FAB495

P921

Q33924814-91BB0466-8FD2-488B-82CF-1BB96FCAD210

P932

Q33924814-C52C4F94-B9A1-43D3-BF9A-DC03219CBBA9

P356

09031936.00145511

P1433

European Respiratory Journal

P1476

Do adjunct tuberculosis tests, ...... is in a resource-poor setting?

@en

P2093

Anil Pooran

http://www.w3.org/2001/XMLSchema#string

Brian Allwood

http://www.w3.org/2001/XMLSchema#string

Grant Theron

http://www.w3.org/2001/XMLSchema#string

Greg Calligaro

http://www.w3.org/2001/XMLSchema#string

Hridesh Kumar Mishra

http://www.w3.org/2001/XMLSchema#string

Jonny Peter

http://www.w3.org/2001/XMLSchema#string

Richard Meldau

http://www.w3.org/2001/XMLSchema#string

Richard van Zyl-Smit

http://www.w3.org/2001/XMLSchema#string

Rod Dawson

http://www.w3.org/2001/XMLSchema#string

Surendra Kumar Sharma

http://www.w3.org/2001/XMLSchema#string

P2860

Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study

Rapid molecular detection of tuberculosis and rifampin resistance

The effect of diagnostic delays on the drop-out rate and the total delay to diagnosis of tuberculosis.

Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology

Are interferon-γ release assays useful for diagnosing active tuberculosis in a high-burden setting?

GeneXpert--a game-changer for tuberculosis control?

Is scale-up worth it? Challenges in economic analysis of diagnostic tests for tuberculosis

The use of an automated quantitative polymerase chain reaction (Xpert MTB/RIF) to predict the sputum smear status of tuberculosis patients.

Interferon release does not add discriminatory value to smear-negative HIV-tuberculosis algorithms.

Chest radiograph reading and recording system: evaluation for tuberculosis screening in patients with advanced HIV.

P304

161-168

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1183/09031936.00145511

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

40

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-11-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51791322

http://www.w3.org/2001/XMLSchema#string

P698

22075479

http://www.w3.org/2001/XMLSchema#string

P921

Akafuba bulwadde

P932

5523948

http://www.w3.org/2001/XMLSchema#string